Trials / Conditions / Metastatic Bladder Carcinoma
Metastatic Bladder Carcinoma
5 registered clinical trials studyying Metastatic Bladder Carcinoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Loc NCT06414317 | Roswell Park Cancer Institute | N/A |
| Recruiting | Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Va NCT05756569 | Emory University | Phase 2 |
| Active Not Recruiting | Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or NCT04940299 | M.D. Anderson Cancer Center | Phase 2 |
| Suspended | Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Gen NCT03375307 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted NCT03866382 | National Cancer Institute (NCI) | Phase 2 |